What Researchers Did
Researchers conducted a systematic review of mandibular osteoradionecrosis (ORN) classifications and evaluated the most suitable one for consistency using blinded independent review of outcome data from the HOPON trial.
What They Found
Out of 16 identified ORN classifications, only the Notani classification was deemed suitable for use as an endpoint in clinical trials. Inconsistencies in classification arose in 19% of patients due to minor bone spicules, which was resolved by adding a distinct category for minor bone spicules to the Notani classification, leading to observer agreement.
What This Means for Canadian Patients
This refined definition of mandibular osteoradionecrosis (ORN) could lead to more consistent and reliable clinical trials for preventing and treating this serious complication of head and neck radiotherapy. For Canadian patients, this means future research on ORN may produce clearer evidence, potentially leading to improved diagnostic accuracy and more effective treatments.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The evaluation of the Notani classification was based on data from a single clinical trial (HOPON), which may limit the generalizability of its refined definition.